{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:48:40Z","timestamp":1782715720525,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health of the Republic of Kazakhstan","award":["No. IRN BR25293294"],"award-info":[{"award-number":["No. IRN BR25293294"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"DOI":"10.1007\/s00253-026-13934-7","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:37:13Z","timestamp":1782715033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative production of recombinant capripoxvirus in Vero cells using microcarrier- and macrocarrier-based dynamic cell culture systems under serum-free conditions"],"prefix":"10.1007","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3987-6814","authenticated-orcid":false,"given":"Zhanat","family":"Amanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2332-2841","authenticated-orcid":false,"given":"Zhanna","family":"Sametova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-6246","authenticated-orcid":false,"given":"Olga","family":"Chervyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9515-0655","authenticated-orcid":false,"given":"Sholpan","family":"Turyskeldy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9484-0540","authenticated-orcid":false,"given":"Alina","family":"Kurmasheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-2491","authenticated-orcid":false,"given":"Ruslan","family":"Abitayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3639-3793","authenticated-orcid":false,"given":"Abdurakhman","family":"Ussembay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8224-8047","authenticated-orcid":false,"given":"Zhanat","family":"Kondibayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3166-4515","authenticated-orcid":false,"given":"Dariya","family":"Toktyrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3892-0032","authenticated-orcid":false,"given":"Dana","family":"Mazbayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4238-5116","authenticated-orcid":false,"given":"Kuandyk","family":"Zhugunissov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-4219","authenticated-orcid":false,"given":"Yerbol","family":"Bulatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"13934_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14201631","volume":"14","author":"Z Amanova","year":"2025","unstructured":"Amanova Z, Sametova Z, Chervyakova O, Turyskeldi S, Kurmasheva A, Abitayev R, Ussembay A, Kondibayeva Z, Toktyrova D, Mazbayeva D, Bulatov Y (2025a) BelloStage\u2122-3000 bioreactor versus conventional cultivation of recombinant capripoxvirus expressing Brucella antigens in Vero cells: a step towards the development of a new human brucellosis vaccine. Cells 14:1631. https:\/\/doi.org\/10.3390\/cells14201631","journal-title":"Cells"},{"key":"13934_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biology14101455","volume":"14","author":"Z Amanova","year":"2025","unstructured":"Amanova Z, Sametova Z, Turyskeldy S, Kurmasheva A, Abitayev R, Ussembay A, Kondibayeva Z, Toktyrova D, Mazbayeva D, Nurabayev S, Kerimbayev A, Bulatov Y (2025b) Efficient serum-free rabies virus propagation using BSR and Vero cell lines: a comparative evaluation of BioNOC II\u00ae macrocarriers in the BelloStage\u2122-3000 bioreactor versus conventional microcarriers. Biology (Basel) 14:1455. https:\/\/doi.org\/10.3390\/biology14101455","journal-title":"Biology (Basel)"},{"key":"13934_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1128\/IAI.01017-08","volume":"77","author":"AM Arenas-Gamboa","year":"2009","unstructured":"Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Gomez G, Rice-Ficht AC (2009) The Brucella abortus S19 \u0394vjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB\/c mice when delivered in a sustained-release vehicle. Infect Immun 77:877\u2013884. https:\/\/doi.org\/10.1128\/IAI.01017-08","journal-title":"Infect Immun"},{"key":"13934_CR4","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1016\/j.vaccine.2020.03.041","volume":"38","author":"DM Berrie","year":"2020","unstructured":"Berrie DM, Waters RC, Montoya C, Chatel A, Vela EM (2020) Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor. Vaccine 38:3639\u20133645. https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.041","journal-title":"Vaccine"},{"key":"13934_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01157-2","volume":"10","author":"L Bourigault","year":"2025","unstructured":"Bourigault L, Bresson C, Jean C, Chevalard C, Kloutz M, Soulet D, Pelissier F, Richard S, Bassard I, S\u00e8ve N, Charretier C, Pain B (2025) Characterization of a suspension Vero cell line for viral vaccine production. NPJ Vaccines 10:114. https:\/\/doi.org\/10.1038\/s41541-025-01157-2","journal-title":"NPJ Vaccines"},{"key":"13934_CR6","unstructured":"Centers for Disease Control and Prevention (2023) Estimates human Brucella infections could be four times higher than previously thought. Available at: https:\/\/www.food-safety.com\/articles\/8817-cdc-estimates-human-brucella-infections-could-be-four-times-higher-than-previously-thought (Accessed 9 February 2026)"},{"key":"13934_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9051005","volume":"9","author":"O Chervyakova","year":"2021","unstructured":"Chervyakova O, Tailakova E, Kozhabergenov N, Sadikaliyeva S, Sultankulova K, Zakarya K, Maksyutov RA, Strochkov V, Sandybayev N (2021) Engineering of recombinant sheep pox viruses expressing foreign antigens. Microorganisms 9:1005. https:\/\/doi.org\/10.3390\/microorganisms9051005","journal-title":"Microorganisms"},{"key":"13934_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-023-03659-4","volume":"19","author":"HY Choi","year":"2023","unstructured":"Choi HY, Choi JC, Kang YL et al (2023) Production of a chimeric porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine using a lab-scale packed-bed bioreactor CelCradle. BMC Vet Res 19:105. https:\/\/doi.org\/10.1186\/s12917-023-03659-4","journal-title":"BMC Vet Res"},{"key":"13934_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-21042-2","volume":"24","author":"GG Dagnaw","year":"2024","unstructured":"Dagnaw GG, Mamuye Y, Dejene H (2024) Human and animal brucellosis and risk factors for human infection in Ethiopia: a systematic review and meta-analysis (2015\u20132024). BMC Public Health 24:3495. https:\/\/doi.org\/10.1186\/s12889-024-21042-2","journal-title":"BMC Public Health"},{"key":"13934_CR10","unstructured":"Esco VacciXcell (2026) BioNOC II macrocarriers for cell culture. Available at: https:\/\/escovaccixcell.com\/tide_technology\/cell_attachment\/BioNOC_II (Accessed 5 March 2026)"},{"key":"13934_CR11","doi-asserted-by":"publisher","first-page":"921755","DOI":"10.3389\/fbioe.2022.921755","volume":"10","author":"Z Fang","year":"2022","unstructured":"Fang Z, Lyu J, Li J, Li C, Zhang Y, Guo Y, Wang Y, Zhang Y, Chen K (2022) Application of bioreactor technology for cell culture-based viral vaccine production: present status and future prospects. Front Bioeng Biotechnol 10:921755. https:\/\/doi.org\/10.3389\/fbioe.2022.921755","journal-title":"Front Bioeng Biotechnol"},{"key":"13934_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012030","author":"ML Freire","year":"2024","unstructured":"Freire ML, Machado de Assis TS, Silva SN, Cota G (2024) Diagnosis of human brucellosis: systematic review and meta-analysis. PLoS Negl Trop Dis. https:\/\/doi.org\/10.1371\/journal.pntd.0012030","journal-title":"PLoS Negl Trop Dis"},{"key":"13934_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.vaccine.2004.06.014","volume":"23","author":"NM Frazatti-Gallina","year":"2004","unstructured":"Frazatti-Gallina NM, Mour\u00e3o-Fuches RM, Paoli RL, Silva ML, Miyaki C, Valentini EJ, Raw I, Higashi HG (2004) Vero-cell rabies vaccine produced using serum-free medium. Vaccine 23:511\u2013517. https:\/\/doi.org\/10.1016\/j.vaccine.2004.06.014","journal-title":"Vaccine"},{"key":"13934_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12060563","volume":"12","author":"H Guo","year":"2024","unstructured":"Guo H, Ding X, Hua D, Liu M, Yang M, Gong Y, Ye N, Chen X, He J, Zhang Y, Xu X, Li J (2024) Enhancing dengue virus production and immunogenicity with CelCradle\u2122 bioreactor: a comparative study with traditional cell culture methods. Vaccines (Basel) 12:563. https:\/\/doi.org\/10.3390\/vaccines12060563","journal-title":"Vaccines (Basel)"},{"key":"13934_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.925773","volume":"9","author":"M Heidary","year":"2022","unstructured":"Heidary M, Dashtbin S, Ghanavati R, Mahdizade Ari M, Bostanghadiri N, Darbandi A, Navidifar T, Talebi M (2022) Evaluation of brucellosis vaccines: a comprehensive review. Front Vet Sci 9:925773. https:\/\/doi.org\/10.3389\/fvets.2022.925773","journal-title":"Front Vet Sci"},{"key":"13934_CR16","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1016\/j.vaccine.2019.05.084","volume":"37","author":"H Hou","year":"2019","unstructured":"Hou H, Liu X, Peng Q (2019) The advances in brucellosis vaccines. Vaccine 37:3981\u20133988. https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.084","journal-title":"Vaccine"},{"key":"13934_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13111109","volume":"13","author":"W Ji","year":"2025","unstructured":"Ji W, Chen Z, Zhou J, Yue X, Qiao Z, Wang J (2025) Advances in serum-free suspension culture technology for animal cells and their applications. Vaccines (Basel) 13:1109. https:\/\/doi.org\/10.3390\/vaccines13111109","journal-title":"Vaccines (Basel)"},{"key":"13934_CR18","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/bit.27785","volume":"118","author":"S Kiesslich","year":"2021","unstructured":"Kiesslich S, Kim GN, Shen CF, Kang CY, Kamen AA (2021) Bioreactor production of rVSV-based vectors in Vero cell suspension cultures. Biotechnol Bioeng 118:2649\u20132659. https:\/\/doi.org\/10.1002\/bit.27785","journal-title":"Biotechnol Bioeng"},{"key":"13934_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7774\/cevr.2020.9.1.48","volume":"9","author":"DK Lee","year":"2020","unstructured":"Lee DK, Park J, Seo DW (2020) Suspension culture of Vero cells for the production of adenovirus type 5. Clin Exp Vaccine Res 9:48\u201355. https:\/\/doi.org\/10.7774\/cevr.2020.9.1.48","journal-title":"Clin Exp Vaccine Res"},{"issue":"Suppl 6","key":"13934_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1753-6561-7-S6-P59","volume":"7","author":"A Lennaertz","year":"2013","unstructured":"Lennaertz A, Knowles S, Drugmand JC, Castillo J, Pletincx S, Verhoye L, Remaut E, Peelman L (2013) Viral vector production in the integrity\u00ae iCELLis\u00ae single-use fixed-bed bioreactor, from bench-scale to industrial scale. BMC Proc 7(Suppl 6):P59. https:\/\/doi.org\/10.1186\/1753-6561-7-S6-P59","journal-title":"BMC Proc"},{"key":"13934_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/biot.202000020","volume":"16","author":"HP Lesch","year":"2021","unstructured":"Lesch HP, Valonen P, Karhinen M (2021) Evaluation of the single-use fixed-bed bioreactors in scalable virus production. Biotechnol J 16:2000020. https:\/\/doi.org\/10.1002\/biot.202000020","journal-title":"Biotechnol J"},{"issue":"7","key":"13934_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070706","volume":"9","author":"A Offersgaard","year":"2021","unstructured":"Offersgaard A, Duarte Hernandez CR, Pihl AF, Costa R, Venkatesan NP, Lin X, Van Pham L, Feng S, Fahn\u00f8e U, Scheel TKH, Ramirez S, Reichl U, Bukh J, Genzel Y, Gottwein JM (2021) SARS-CoV-2 production in a scalable high cell density bioreactor. Vaccines (Basel) 9(7):706. https:\/\/doi.org\/10.3390\/vaccines9070706","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"13934_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020249","volume":"10","author":"A Offersgaard","year":"2022","unstructured":"Offersgaard A, Duarte Hernandez CR, Pihl AF, Venkatesan NP, Krarup H, Lin X, Reichl U, Bukh J, Genzel Y, Gottwein JM (2022) High-titer hepatitis C virus production in a scalable single-use high cell density bioreactor. Vaccines (Basel) 10(2):249. https:\/\/doi.org\/10.3390\/vaccines10020249","journal-title":"Vaccines (Basel)"},{"key":"13934_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2295398","volume":"55","author":"KA Qureshi","year":"2023","unstructured":"Qureshi KA, Parvez A, Fahmy NA, Abdel Hady BH, Kumar S, Ganguly A, Atiya A, Elhassan GO, Alfadly SO, Parkkila S, Aspatwar A (2023) Brucellosis: epidemiology, pathogenesis, diagnosis and treatment\u2014a comprehensive review. Ann Med 55:2295398. https:\/\/doi.org\/10.1080\/07853890.2023.2295398","journal-title":"Ann Med"},{"key":"13934_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints12. Am J Epidemiol 27:493\u2013497. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a118408","journal-title":"Am J Epidemiol"},{"key":"13934_CR26","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1016\/j.vaccine.2007.01.086","volume":"25","author":"S Rourou","year":"2007","unstructured":"Rourou S, van der Ark A, van der Velden T, Kallel H (2007) A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component-free conditions. Vaccine 25:3879\u20133889. https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.086","journal-title":"Vaccine"},{"key":"13934_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.biologicals.2007.02.002","volume":"35","author":"H Toriniwa","year":"2007","unstructured":"Toriniwa H, Komiya T (2007) Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor. Biologicals 35:221\u2013226. https:\/\/doi.org\/10.1016\/j.biologicals.2007.02.002","journal-title":"Biologicals"},{"key":"13934_CR28","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1038\/s41598-024-55034-4","volume":"14","author":"X Wen","year":"2024","unstructured":"Wen X, Wang Y, Shao Z (2024) The spatiotemporal trend of human brucellosis in China and driving factors using interpretability analysis. Sci Rep 14:4880. https:\/\/doi.org\/10.1038\/s41598-024-55034-4","journal-title":"Sci Rep"},{"key":"13934_CR29","doi-asserted-by":"publisher","first-page":"1580265","DOI":"10.3389\/fpubh.2025.1580265","volume":"13","author":"R Zhao","year":"2025","unstructured":"Zhao R, Sun R, Zhang F (2025) Epidemiological characteristics and spatial clustering analysis of human brucellosis in Zibo City, Shandong Province, China, 2006\u20132024. Front Public Health 13:1580265. https:\/\/doi.org\/10.3389\/fpubh.2025.1580265","journal-title":"Front Public Health"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-026-13934-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13934-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:37:19Z","timestamp":1782715039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-026-13934-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13934"],"URL":"https:\/\/doi.org\/10.1007\/s00253-026-13934-7","relation":{},"ISSN":["1432-0614"],"issn-type":[{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve human participants or animal subjects, and therefore no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}